Cleared Abbreviated

K092993 - ADVIA CENTAUR CYCLOSPORINE MASTER CURVE...

K092993 is an FDA 510(k) clearance for ADVIA CENTAUR CYCLOSPORINE MASTER CURVE..., manufactured by Siemens Healthcare Diagnostics. The device is a Class 1 Chemistry device with product code JJX cleared through the Abbreviated 510(k) pathway after a 53-day FDA review.

K092993 · Siemens Healthcare Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2009
Decision
53d
Days
Class 1
Risk

K092993 is an FDA 510(k) clearance for the ADVIA CENTAUR CYCLOSPORINE MASTER CURVE MATERIAL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Siemens Healthcare Diagnostics (Tarrytown, US). The FDA issued a Cleared decision on November 20, 2009 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Siemens Healthcare Diagnostics devices

FDA 510(k) Submission Details - K092993

510(k) Number K092993 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2009
Decision Date November 20, 2009
Days to Decision 53 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 88d · This submission: 53d
Pathway characteristics
Standards-based clearance path.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 402
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K092993.
ELECSYS PROBNP II CALCHECK 5
K092169 · Roche Diagnostics · Dec 2009
LIAISON N-TACT PTH CALIBRATION VERIFIERS MODEL 310913
K093498 · DiaSorin, Inc. · Dec 2009
MAS AND MINI-TROL PTH CONTROL
K092749 · Microgenics Corporation · Dec 2009
ELECSYS HCG+B CALCHECK 5
K092168 · Roche Diagnostics · Nov 2009
ELECSYS TOXO IGG CALCHECK 5
K092888 · Roche Diagnostics Corp. · Nov 2009
OMNIS HEALTH EMBRACE GLUCOSE CONTROL SOLUTION
K091914 · Bionostics, Inc. · Nov 2009